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INTRODUCTION 
Many different chemicals are used by the modern farmer in the produc-
tion of agricultural commodities. Chemicals, utilized to increase pro-
ductivity, include insecticides, herbicides, fertilizers, and a wide 
variety of feed additives. Many producers are apparently not well in-
formed of the consequences that may result following misuse of these 
products. Product misuse has caused the death of livestock and/or the 
establishment of unacceptable levels of chemical residues in animal tis-
sues. 
The sulfonamides, especially sulfamethazine, have been used since the 
1960s as. feed additives in swine rati ans. Sulfamethazi ne, in combination 
with certain antibiotics, has been incorporated extensively in rations 
formulated for young swine. Unfortunately, approximately 12% of the tis-
sues from hogs marketed for human consumption tested by the Food Safety 
and Quality Service (FSQS) of the United States Department of Agriculture 
(USDA) from lg74 to 1977 contained tissue concentrations greater than the 
tolerance limit of 0.10 µg/g established by the Food and Drug Administra-
tion (FDA) (Trabosh, 1978a). Some swine producers claimed that test 
procedures used by FSQS were not accurate at lower concentrations and that 
tissue mishandling could result in erroneously high test results. 
This research was designed to determine if tissue mishandling could 
result in a change in the result obtained by the "official" FSQS procedure 
for quantitation of sulfamethazine levels in swine liver and muscle. 
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LITERATURE REVIEW 
General Background 
Sulfonamides were the first effective systemic antimicrobial com-
pounds developed for medical usage. With their introduction, the era of 
modern antimicrobial chemotherapy began. These compounds quickly became 
the primary chemical defense against many infectious microorganisms. The 
use of sulfonamides for treatment of acute bacterial diseases declined 
following introduction of penicillin and other antibiotics. Sulfona-
mides are still used in specific situations where they are the most effec-
tive treatment and as feed additives for disease prevention and growth 
promotion. 
The parent compound for the sulfonamides, sulfanilamide, p-amino-
benzene-sulfonamide, was first synthesized by Gelmo (1908) for possible 
use in the dye industry. Significant medical usage of the sulfonamides 
was not reported until 1935, when Domagk (1935a,b,c) reported that Pronto-
sil, 2:4 diaminoazobenzene-4-sulfonamide, protected mice from a highly 
pathogenic strain of hemolytic streptococcus and reduced the severity of 
staphylococcal infections in rabbits. The protective action of Prontosil 
in experimental streptococcal infections was soon confirmed by Levaditi 
and Vaisman (1935). 
A group of French scientists, Trefouel et al. (1935) and Fourneau 
et al. (1936), hypothesized that Prontosil was broken down'in vivo at the 
azo linkage to produce sulfanilamide, p-aminobenzene-sulfonamide. They 
reported that sulfanilamide was as effective as Prontosil in preventing 
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fatal streptococcal infections in experimental animals and also demon-
strated that sulfanilamide was active not only in vivo but also.:!.!! vitro. 
Prontosil was not active in vitro. Suttle et al. (1936) soon confirmed 
the work of Fourneau et al. (1936), reporting that p-aminobenzene-
sulfonamide paralleled Prontosil in therapeutic activity and was capable 
of curing experimental meningococcal infections in mice. 
Sulfanilamide was soon used successfully by many investigators to 
treat several types of bacterial diseases in man. Heintzelman et al. 
(1937) reported favorable clinical results in ten cases of meningococcal 
meningitis treated with sulfanilamide. 
Attempts to elucidate the mode of action of this compound were ad-
vanced by Stamp's (1939) discovery that streptococcal extracts neutralized 
the bacterial inhibitory action of sulfanilamide. Woods (1940) found that 
a yeast extract also contained a similar inhibitory substance and that 
these substances had the same physical and chemical properties as para-
ami no-benzoic acid (PABA). Woods (1940) postulated that sulfanilamide 
interfered in the utilization of PABA in some bacterial enzyme reactions. 
A system of nomenclature for sulfanilamide derivatives was developed 
by Crossley et al. ()938a,b,c). The parent compound, sulfanilamide,may be 
modified by substituting other groups for any of the hydrogens in the 
compound. The sulfanyl group (-S02NH 2) is the most important functional 
group and is assigned the number one position on the ring; derivatives of 
the amide nitrogen in this position are designated N1 substituents. In 
the same manner, derivatives of the amino-nitrogen are designated as N4 
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substituents (Bevill, 1982). Figure 1 shows the chemical structure of 
sulfanilamide. 
One of the sulfanilamide derivatives selected for commercial usage 
was a compound named sulfamethazine, (sulfadimidine), N1-(4, 6-dimethyl-
2-pyrimidinyl) sulfanilamide. This compound is a white to yellowish-
white powder which by definition contains not less than 99.0% and not more 
than 100.5% sulfamethazine when calculated on the dry weight basis (The 
United States Pharmacopeia, 1970). The compound has a molecular weight of 
278.33 and its empirical formula is c12N14o2N4s. It is almost odorless 
and has a slightly bitter taste. It is very slightly soluble in water and 
ether, slightly soluble in alcohol and soluble in acetone (Wood, 1955). 
Sulfamethazine may be prepared by reacting acetylsulfanilyl chloride with 
2 amino-4, 6 dimethylpyrimidine in pyridin, followed by alkaline hydrol-
ysis to the 2 (N4-acetylsulfanilamido)-4, 6 dimethyl pyrimidine, the re-
sulting sodium salt being neutralized with so2 (Wendholz, 1976). Sulfa-
methazine is amphoteric and forms salts in strongly acidic or basic solu-
tions. Proton acceptance at N4 accounts for its behavior as a base in 
acidic solutions. The sodium salt of sulfamethazine is more soluble in 
water than the parent compound and the solubility of the sodium salt in-
creases as pH increases (Bevill and Huber, 1977). 
Mechanism of Action 
Woods (1940) postulated that sulfanilamide competed with para-amino-
benzoic acid (PABA) for an enzymatic site in the formation of an essential 
bacterial metabolite since both compounds are similar in chemical struc-
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COCH 
Para-aminobenzoic Acid 
Sul fanilamide 
Sulfamethazine 
Figure 1. Structural formulas of para-aminobenzoic acid, sulfanilamide, 
and sulfamethazine 
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ture. This theory was strengthened by the discovery that sulfonamides 
competitively blocked the enzymatic coupling of PABA and 2-amino-4-
hydroxytetrahydropteridine, a step necessary in the formation of folic 
acid (Lehninger, 1975). Folic acid is converted into its coenzyme form, 
tetrahydro-folic acid (FH4) by reduction. Tetrahydro-folic acid serves as 
an intermediate carrier of methyl, formyl, or hydroxymethyl groups in 
several enzymatic reactions in which one-carbon groups are transferred 
from one intermediate metabolite to another. Included are transfer reac-
tions in connection with the intermediary metabolism of purines, pyrimi-
dines, and amino acids necessary for biosynthesis of nucleotides, the 
direct precursors of deoxyribonucleic acid (DNA) and ribonucleic acid 
(RNA) (Lehninger, 1975). Sulfonamides, by inhibiting the formation of 
folic acid, exert a bacteriostatic effect on some bacteria. Sulfonamide-
susceptible bacteria must produce folic acid from its components. Such 
bacteria are unable to utilize the preformed folic acid found in animal 
tissues. 
Absorption, Metabolism, and Excretion 
Sulfonamide absorption and movement from its site of administration 
is governed by passive diffusion. The rate of absorption is influenced by 
several factors including vascularity of the absorption site, extent of 
binding with material present at the administration site, and ionization 
state and lipophilicity of the drug (Bevill, 1982). Orally administered 
sulfamethazine is rapidly absorbed by healthy swine (Linkenheimer and 
Stolzenberg, 1965). The rate of absorption in diseased swine may be 
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altered. The rate of sulfamethazine absorption was significantly in-
creased in milk-fed calves with diarrhea (Lapka et al., 1978). In con-
trast, water deprivation has been shown to slow the absorption of sulfa-
ethoxypyridazine from the intestinal tract of cattle (Heath and Teske, 
1973). 
Distribution of sulfonamides from the blood into various tissues and 
other biological fluids is influenced by the ionization state of the 
sulfonamide, vascularity of the tissues, plasma protein binding to the 
sulfonamide and the presence of specific barriers to sulfonamide diffusion 
(Bevill, 1982). Passive diffusion governs the movement of the sulfonamide 
from blood to other fluids and tissues and the concentration attained in 
these tissues is a measure of the rate at which the drug equilibrates 
between blood plasma and these tissues. Eventually, a plasma-tissue 
equilibrium is established and this equilibrium occurs first in highly 
vascularized tissues. Once this equilibrium is established, a constant 
relationship exists between the concentration of the sulfonamide in plasma 
and that present in a specific tissue (Bevill, 1982). Tissue concentra-
tions of sulfonamides are usually lower than plasma values. Studies in 
cattle, sheep, and swine have shown that the disappearance of a specific 
sulfonamide from plasma and tissues occurs at similar rates within a given 
species (Bourne et al., 1977; Bevill et al., 1977a,b). The half-life of 
sulfamethazine in swine plasma is 14-16 hours (Bevill and Huber, 1977). 
Bevill et al. (1977a) reported that sulfamethazine metabolism fits a 
one compartment pharmacokinetic model in cattle. Sulfamethazine was 
eliminated as the parent compound and three metabolites: acetyl and 
8 
hydroxy derivatives and a polar metabolite. Similar excretion products 
were obtained in lamb studies with sulfamethazine (Bevill et al., 1977b; 
Bourne et al., 1977). The metabolism of sulfamethazine in lambs also fits 
a one compartment pharmacokinetic model (Dittert, 1977). Swine excrete 
sulfamethazine similarly but apparently are unable to hydroxylate sulfa-
methazine, as hydroxylated metabolites have not been found in swine urine 
following oral or intravenous administration of the compound (Bevill and 
Huber, 1977). 
Usage and Residue Problems 
Sulfonamides have been used extensively in the swine industry, and it 
has been estimated that 75% of the swine slaughtered in the United States 
received some sulfonamide during their relatively short lifetime (Crom-
well, 1979). Sulfamethazine-antibiotic combinations in feed have been 
shown to be effective in improving growth rate and feed efficiency 
(Elliott et al., 1964; Melliere et al., 1968). This effect appears to be 
greatest in swine herds with chronic respiratory problems and young pigs 
appear to benefit the most. Sulfamethazine is approved for use as a feed 
additive in combination with certain antibiotics. These combinations in-
clude tylosin with sulfamethazine and a combination of three drugs: 
chlorotetracycline, sulfamethazine, and procaine penicillin. The level of 
sulfamethazine approved in these combinations is 100 grams per ton of com-
plete feed (Leidahl, 1980). 
The improper use of sulfonamides has resulted in a persistent problem 
of sulfonamide residues in swine tissues. The FSQS of the USDA began a 
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sulfonamide residue monitoring program in 1973. The initial violation 
rate for these compounds was over 10% and the rate continued to be over 
10% through 1977. The number of swine tissue samples collected for analy-
sis rose from 300 per year in 1974 to 9,410 in 1977. The violation rate 
dropped to 5.7% of 3,488 samples collected in 1981 (personal communica-
tion, L. R. Hensley, Residue Evaluation and Planning Division, FSIS, 
Washington, D.C., 1983). Residue levels or concentrations of sulfonamides 
over 0. l µg/g or 0.1 part per million (ppm) in liver, kidney, or muscle 
are in violation (Federal Register, 1982). Tissues containing concentra-
tions of a sulfonamide above 0. l µg/g are considered adulterated and unfit 
for human consumption; however, marketing practices result in movement of 
the meat to the retail level before laboratory results are completed, 
except in herds with previous violations. 
The reliability of the methods used by FSQS personnel to obtain these 
results has been questioned (Horwitz, 1981). The procedure utilized three 
different methods to identify and quantitate the sulfonamide levels in 
tissues. The samples were initially screened using a thin layer chromato-
graphic (TLC) test. Positive samples were then analyzed using a gas-
1 iquid chromatographic (GLC) procedure to identify the specific sulfona-
mide(s) present in the tissue sample. The amount of sulfonamide was then 
quantitatively determined by the Tishler method, option A (Horwitz, 1981). 
The Tishler method (Tishler et al., 1968) is a colorimetric method 
which utilizes the Bratton-Marshall coupling reaction (Bratton and 
Marshall, 1939) and visible spectrophotometric techniques. The FSQS 
personnel believed that the combination of testing procedures reduced the 
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possibility of "false positives" or incorrect high results. The use of 
the colorimetric procedure for final quantitation was probably the weakest 
point in the entire testing regime. Although "clean-up" steps in the pro-
cedure remove some compounds that also couple with the Bratton-Marshall 
reagent, they do not remove all such compounds. The coupling reaction is 
nonspecific and primary aromatic amines other than sulfonamides may react 
in a similar manner. Low levels of two or more sulfonamides could be 
added together in this procedure. The Bratton-Marshall (B-M) procedure 
was originally developed to measure much higher levels: 0.5-1.0 mg/dl of 
sulfonamides in blood and urine (Bratton and Marshall, 1939). This proce-
dure was later adapted by Tishler et al. (1968) for use on milk and tis-
sues. 
The advantages of the Tishler tissue procedure were speed of analy-
sis, consistent recovery, and relatively inexpensive equipment necessary 
to perform the extraction and final readout. 
Tishler et.al. (1968) believed their procedure to be sensitive to at 
least 0.1 µg/g with a minimum recovery rate of 75%. Their results showed 
that sulfonamide-free control tissue could account for as much as 39±8 
ng/g of the total measured in certain tissues. This amount was not con-
sidered by the authors to be significant, although in some cases, the con-
trol tissue would apparently account for one-half the total amount of 
"sulfonamide" measured. Similar or higher levels have been reported for 
sulfonamide-free control tissues as measured by the Tishler procedure 
(Righter et al., 1971; Lloyd et al., 1981). This added amount would be 
sufficient to cause a tissue sample containing a true sulfonamide level of 
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less than 0.1 µg/g, i.e., 0.06-0.09 µg/g, to measure greater than 0. 1 µg/g 
and thus be considered to be in violation. In November 1979, Dr. Richard 
Ellis announced that the FSQS chemistry division was revising the method 
used to quantitate the amount of sulfonamides in swine tissues (USDA-
APHIS, 1979). The chemistry division would replace the Tishler option C 
of the Bratton-Marshall test with the Tishler option A and would begin 
deducting a set background value of 0.05 µg/g from values obtained on 
liver and 0.02 µg/g from values obtained for muscle. They believed this 
correction would more accurately reflect the true sulfonamide residue in 
the tissue. 
From June 1977 to January 1978, 13.3% of the tissues tested were 
found to have violative sulfonamide levels. Tissue concentrations of 
0.11-0.20 µg/g were responsible for approximately 30% of the sulfonamide 
violations in liver tissues (Trabosh, 1978b). From January 1980 to Decem-
ber 1980, 5.6% of the swine tissues tested were found to have violative 
sulfonamide levels. Tissue concentrations of 0.11-0.20 µg/g were re-
sponsible for only 17.7% of the sulfonamide violations in liver tissues 
(Trabosh, 1981). This drop was apparently due, in par_t, to increased pro-
ducer awareness of the problem and by the elimination of tissues which in 
the past would have been in violation, those which measured 0.10-0.14 
µg/g, prior to subtracting the background amount of 0.05 ppm. The Tishler 
modification of the B-M procedure has been referred to as the "official" 
method for testing animal tissues for residues of sulfonamides. No col-
laborative study to validate this method could be found during an exten-
sive search of the literature. Although various internal memoranda of the 
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Food and Drug Administration (FDA) and FSQS have stated that the Tishler 
method is the method of choice for examining animal tissues for sulfona-
mides, no statement could be found in any FDA regulations to support its 
alleged "official" status (Horwitz, 1981). 
On February 1982, the Food Safety and Inspection Service (FSIS), 
previously FSQS, announced a policy change regarding acceptable methods 
for analyzing poultry and red meat tissues for sulfonamide drug residues 
(Anon., 1982). This announcement stated that on March 24, 1982, the FSIS 
field laboratories would discontinue the use of the Tishler A B-M method 
and would be implementing the sulfonamide thin-layer chromatography (STLC) 
method for determination of sulfonamides in poultry and red meat as the 
initial analysis of all tissue samples. If the results showed that these' 
tissues contained 0.11-0.15 µg/g sulfonamides, the results would be con-
firmed by the gas chromatography/mass spectrometry (GC/MS) method before 
being reported as official (Anon, 1982). 
Thin layer chromatography and GLC methods had been used previously by 
FSQS laboratory personnel. Unfortunately, recovery was low and deviation 
was high and these methods could not be used for quantitation until these 
problems were solved. A collaborative study to evaluate new GC and GC/MS 
methods determined that the GC/MS procedure provided the most reliable 
data and that the STLC method provided acceptable data if appropriate con-
trols were used (Malanoski et al., 1981). No reports of a collaborative 
study on the STLC method could be found. 
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Methods of Analysis 
Colorimetric 
A wide variety of amines and phenols have been used to couple with 
diazotized sulfonamides. These include N-1-naphthyl-N'-dietylpropylene-
diamine monohydrochloride, 1-(B-diethylaminoethylamino) naphthalene free 
from 1-naphthylamine, dimethyl-a-naphthylamine, ethyl-a-naphthylamine, 
l-aceta-amido-8-naphthol-3,6-dilsulfonic acid, l-amino-8-naphthol-3, 
6-disulfonic acid, N-B-sulfatoethyl-m-toluidine,diphenylamine, a-naphthyl-
amine, thymol, a-naphthol and B-naphthol (Snell and Snell, 1954). These 
compounds were replaced by a new coupling compound, N-(1-naphthyl) ethyl-
enediamine dihydrochloride (NEDA), developed by Bratton and Marshall 
(1939). This compound offered several advantages over other compounds 
used and became the primary compound used for coupling with the sulfona-
mides during analysis. The Bratton-Marshall method was later utilized by 
Tishler et al. (1968) in the development of a sensitive colorimetric 
method for determining sulfonamide concentrations in tissues and milk. 
The basic reactions following extraction from the tissues are that the 
sulfonamide is converted to a diazonium salt by the action of sodium 
nitrite. Ammonium sulfamate is used to neutralize excess sodium nitrite 
and the diazotized sulfonamide is coupled with NEDA. The amount of the 
resulting coupled complex is determined by measuring the absorbance of the 
sample and standard solutions against their respective blanks at 545 nm. 
A simple qualitative screening test for primary aromatic amines in 
swine feeds using the Bratton-Marshall method has recently been developed 
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(Schwartz, 1982). This test is capable of detecting sulfamethazine levels 
of .::_0.15 ppm. 
The majority of colorimetric methods has been based on these reac-
tions with NEDA as the final coupling reagent. 
New methods for sulfonamide analysis using chloramine-T in spectro-
photometric and titrimetric analyses have been developed (Trieff et al., 
1977); however, these methods have not been accepted by FSIS for tissue 
analysis. 
Chromatographic methods of analysis 
Thin-layer chromatographic (TLC), gas-liquid chromatography (GLC), 
and high performance 1 iquid chromatography (HPLC) have been used for the de-
termination of sulfonamide concentration in animal feed, tissues, and 
plasma. 
Thin-layer chromatography methods have been used for the determina-
tion of sulfonamides in feeds (Cieri, 1976; Luchtefeld, 1976), plasma 
(Bevill et al., 1978) and tissues (Thomas et al., 1981; Phillips and 
Trafton, 1975). Cieri (1976) used an alcoholic solution of p-dimethyl-
aminobenzaldehyde to detect sulfonamides on TLC plates after extraction 
from feeds. Identification of the specific sulfonamide was based on its 
RF value in comparison to standards. Quantitation was based on dilution 
and color intensity. Luchtefeld (1976) used N-(1-naphthyl) ethylene 
diamine (NEDA) to detect the sulfonamide on the plate and quantitation was 
based on dilution and color intensity. These methods are dependent on 
visual observation of the "spot" formed by the coupling reagent and the 
sulfonamide. 
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Thomas et al. (1981) developed a method that appears to be more 
sensitive. After extraction and development, the dry TLC plates are 
dipped in a fluorescamine solution. The fluorescamine-sulfonamide complex 
is then determined using scanning densitometry. The same detection method 
(Bevill et al., 1978) was used for plasma samples following various ex-
traction procedures. 
High performance liquid chromatographic methods have been used for the 
determination of sulfonamide concentrations in urine (Sharma et al., 
1976), tissues (Johnson et al., 1975) and serum (Goehl et al., 1978). 
After extraction from the biological matrix, the sample is injected onto a 
specific column. Methanol is used to move the injected material along the 
column and the column eluants are read at 254 nm and/or 280 nm. 
GLC methods have been used for the determination of sulfonamides in 
feed (personal communication, D. Sullivan, Vet A Mix, Shenandoah, Iowa, 
1977) and swine tissues (Goodspeed et al., 1978; Manuel and Steller, 
1981). The sulfonamide is extracted from the biological matrix, parti-
tioned into an organic solvent, methylated with diazomethane and injected 
onto a specific column. Nitrogen or an argon-methane mixture of gases is 
used to move the injected material along the column and methylated com-
pounds passing the detector are measured. 
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MATERIALS AND METHODS 
Treatment Conditions 
Time study 
Six pigs were used for the time study. These animals were divided 
into two groups with three animals in each group. The pigs were fed one 
of two complete feeds for a minimum of ten days prior to slaughter. One 
group received sulfamethazine-free feed and the other group received feed 
containing 11 .0 ppm sulfamethazine. The animals were housed individually 
in pens with concrete floors measuring approximately 3 x 3 meters. Pens 
were cleaned daily using shovels and water flushes. Water was suppled~ 
libitum via nipple watering devices. Feed was supplied ad libitum via 
metal self-feeders. 
Freeze-thaw study 
Three pigs were used for the freeze-thaw study. These animals were 
housed individually in pens with concrete floors measuring approximately 
3 x 5 meters. Pens were cleaned daily using shovels and water flushes. 
Water was supplied ad l ibitum via open water pans. Feed was supplied ad 
libitum via metal self-feeders. These animals received control feed for a 
minimum of ten days prior to slaughter. 
Feed preparation 
A complete control feed was prepared in a tractor powered grinder-
mixer. The control feed components consisted of shelled corn, soybean 
meal, and a commercially prepared vitamin-mineral premix. Analysis of the 
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feed components and the finished control feed by GLC failed to reveal the 
presence of any sulfonamide (less than .10 ppm). 
A portion of the control feed was mixed with similar feed containing 
109.8 ppm sulfamethazine to produce a finished product contai.ning 11.0 ppm 
sulfamethazine. 
Sample Collection and Preparation - Time Study 
Time study 
One animal was killed on each of three consecutive days. The animals 
were electrocuted and exsanguinated. After the skin and subcutaneous fat 
were removed, samples of liver and gluteal muscle were collected for proc-
essing. Maximum care was taken to insure the tissues collected were not 
contaminated by skin, fecal material, or urine. 
The livers were cut into pieces approximately 1 cm3. These pieces 
were mixed manually and randomly divided into two groups. One group was 
ground into a puree in a food blender. The resultant puree was poured 
into polyethylene bags, with approximately 50 grams of tissue in each bag. 
The other group of liver pieces was placed in polyethylene bags, with 
approximately 50 grams of tissue in each bag. 
The muscle collected was trimmed free of visible fat, cut into pieces 
approximately 3 cm3, chopped in a cast iron meat grinder, mixed manually, 
and placed in polyethylene bags with approximately 50 grams of tissue in 
each bag. 
The polyethylene bags were identified as to tissue type and numbered. 
The bags were then selected randomly for the amount of time they would be 
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allowed to remain at 23°C. Samples selected as "O" hour samples were 
placed in a freezer at -23°C approximately 1 hour after the animals were 
killed. All other bags were spread out on an elevated tray in a covered 
water bath. Water bath temperature, 23°C, was monitored to assure that 
the temperature remained constant. Samples were then removed from the 
water bath at the following times: 6 hours, 12 hours, 24 hours, 48 hours, 
and 96 hours. These times were based on time expired from the time the 
animals were killed. Samples removed from the water bath were placed 
immediately in a freezer at -23°C. 
Sample Collection and Preparation - Freeze-Thaw Study 
Freeze-thaw study 
Facilities at the Iowa State University Meat Laboratory were used to 
process these animals. 
All animals were killed on the same day at approximately one-half 
hour intervals. Animals were stunned using a captive bolt device and 
exsanguinated. Animals were then lowered into a vat of boiling water and 
the hair was removed by automated machinery, followed by manual clean-up. 
The body cavities were opened and the livers were removed. The 
livers were cut into pieces approximately 1 cm3 and mixed manually. The 
pieces were placed in polyethylene bags with approximately 50 grams of 
liver per bag. The polyethylene bags were identified and numbered. The 
bags were then randomly selected for the number of freeze-thaw cycles to 
which they were subjected. All samples were placed in a freezer at -23°C. 
Samples were selected to undergo 0, 1, 2, or 3 freeze-thaw cycles. Sam-
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ples selected to undergo zero freeze-thaw cycles were left in the freezer 
until used for analysis. The other samples were removed from ~e freezer 
after 24 hours and placed in a covered water bath at 23°C for 2 hours. 
They were then returned to the freezer until used for analysis. This 
process was repeated for the samples until they had been subjected to the 
predetermined number of freeze-thaw cycles. These samples were all re-
turned to the freezer until they were analyzed. 
Extraction Procedure for Liver and Muscle 
The following procedure was used to extract sulfamethazine from the 
liver and muscle. Fifty grams of tissue were weighed from the original 
sample by shaving the frozen tissue into a sample cup. This tissue was 
then transferred to a glass blender jar. One hundred ml of a 50:50 
acetone-chloroform (A:C) mixture wereadded and the mixture was blended at 
low speed for 1 minute. The fluid in the blender jar was filtered through 
Whatman #1 filter paper and glass wool into a 500 ml round bottom flask. 
An additional 100 ml of A:C mixture was then blended for 1 minute at low 
speed. The fluid in the blender jar was filtered through the same filter 
paper and glass wool into the same 500 ml round bottom flask. This proc-
ess was repeated with a third 100 ml portion of A:C mixture. The filter 
paper and tissue in the filter paper were added to the contents of the 
blender jar and this mixture was blended for one minute at low speed. The 
fluid was then filtered through a new Whatman #1 filter paper into the 
same 500 ml round bottom flask. A final 100 ml portion of A"C mixture was 
added to the contents of the blender jar. The contents were blended for 1 
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minute. The fluid was then filtered into the same round bottom flask. 
Ten ml of lN HCl were added to the contents of the round bottom flask and 
the flask was then placed on a rotary evaporator and the A:C mixture was 
evaporated from the flask using a combination of vacuum and heat. The 
remaining acid extract was transferred to a 250 ml separatory funnel. The 
500 ml round bottom flask was rinsed using the following sequence of 
solvents: 25 ml hexanes (reagent grade), 25 ml hexanes, 3 ml acetone, 25 
ml hexanes, 3 ml hexanes, 3 ml acetone, and 25 ml hexanes. Each rinse was 
added to the separatory funnel and the separatory funnel was shaken gently 
for 2 minutes and allowed to stand for 15 minutes. The lower (acid) layer 
was filtered through 9.0 cm glass fiber, Whatman grade GF/A filter paper 
into a 50 ml graduated cylinder. The 500 ml round bottom flask was rinsed 
with 5 ml lN HCl and this portion was transferred to the separatory funnel. 
The separatory funnel was shaken gently for 1 minute and allowed to stand 
for 15 minutes. The lower layer was filtered through GF/A filter paper 
into the same 50 ml graduated cylinder. This process was repeated with 
another 5 ml of lN HCl. Then, lN HCl was added to the graduated ·cylinder 
to adjust the total volume to 30 ml. The sample was mixed and 15 ml of 
the sample were used for the colorimetric procedure. The remaining 15 ml 
were used for the GLC procedure. 
The 15 ml portion of the sample used for the GLC procedure was trans-
ferred to a 60 ml polypropylene bottle. Nine and one-half grams of sodium 
citrate·2H2o were added and the bottle was shaken until the sodium 
citrate·2H2o was dissolved. 
to pH 5.5-5.6 with 4N ·NaOH. 
The pH of the resultant mixture was adjusted 
The samp 1 e was then poured into a 250 ml 
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separatory funnel. The bottle was rinsed with 25 ml methylene chloride 
(MeC1 2) which was added to the contents of the separatory funnel. The 
funnel was shaken gently for 1 minute and allowed to stand for 5 minutes 
for the phases to separate. The lower MeC1 2 phase was filtered through 
Whatman #40 paper into a pear-shaped 100 ml TS 24/40 flask. The MeC1 2 
extraction was repeated with two separate 15 ml portions, and all extracts 
were combined in the same 100 ml pear-shaped flask. The MeC1 2 extracts 
were evaporated to dryness on a rotary evaporator. One-half ml of an-
hydrous methanol was added to the flask. The flask was swirled occasion-
ally during the next 15 minutes. One-half ml diazomethane solution was 
added to the flask. The flask was swirled occasionally during the next 15 
minutes. The contents of the flask were evaporated to dryness over N2 at 
room temperature. A known volume of ethyl-acetate:isooctane (1 :1) was 
added to the flask to dissolve the residue and give adequate peak height 
vs. minimum amount of background on the gas chromatograph. 
Color Development 
The 15 ml sample for color development was divided and 7.5 ml were 
placed in each of two test tubes. One ml of 0.1% sodium nitrite was added 
to each. The contents of the tubes were blended on a vortex mixer and 
allowed to stand for 3 minutes. One ml of 0.5% ammonium sulfamate was 
added to each tube. The contents of the tubes were combined on a vortex 
mixer and allowed to stand for 2 minutes. One-half ml N-(1-naphthyl) 
ethylenediamine dihydrochloride (NEDA) was added to one tube and 1/2 ml 
of water was added to the second tube. The contents of the tubes were 
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mixed on a vortex mixer and allowed to stand for 20 minutes. Sample 
absorbances were measured on a spectrophotometer set at a wave-length of 
545 nm (Bausch & Lomb, Rochester, New York). 
Calculation: 
The amount of sulfamethazine in each sample was calculated using the 
following formulas. 
where 
As - AN - Aw 
Astd = ANS - Aws 
Sample ppm 
As 
=--x 
A std 
x 100 
R 
µg sulfamethazine in standard volume 
w 
As = net absorbance of unknown sample 
AN = absorbance of sample tube with NEDA 
Aw = absorbance of sample with distilled water 
A std = absorbance of standard used that day 
ANS = absorbance of standard with NEDA 
Aws = absorbance of standard tube receiving distilled water 
VS = volume of acid extract of sample 
Vstd = volume of acid used to dissolve standard 
W = weight of sample in grams 
R = percent recovery for the samples extracted that day 
To determine R, or percent recovery, the following procedure was 
used. Two or three samples were "spiked" with 5.0 µg sulfamethazine dis-
solved in methanol. One ml of methanol containing 5.0 µg of sulfametha-
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zine was added to a tissue sample before the extraction procedure was 
begun. A duplicate sample was also extracted with no added sulfametha-
zine. The absorbances of both samples were measured after color develop-
ment. The difference in absorbance between the samples was considered to 
be that contributed by the added "spike." This difference in absorbance 
was converted to µg sulfamethazine and, divided by the µg sulfamethazine in 
the 1 ml "spike." 
A standard curve was established over a wide range of sulfamethazine 
concentrations. This was accomplished by adding O.O, 2.5, 5.0, 10.0, 
15.0, 25.0, 125.0, and 250 µg sulfamethazine to individual 50 ml graduated 
cylinders. Each cylinder was brought to 30 ml with 2N HCl. Color was de-
veloped as explained above. Net absorbances Astd were then plotted (Y 
axis) on coordinate paper against concentration (X axis). 
Gas Chromatographic Analysis of Sulfamethazine 
The samples were analyzed for sulfamethazine on a Packard 600 gas 
liquid chromatograph (Packard Instrument Co., Downers Grove, Ill.) fitted 
with a 63N: electron capture detector. The oven was equipped with a six 
feet long glass column, 1/4 in outside diameter and 1/8 in inside diame-
ter, filled with 5% OV-7 gas chroma Q 100/120 mesh packing. The oven 
temperature was maintained at 270°C. The injection vaporizer was set at 
280°C and the detector block was kept at 300°C. Nitrogen was used for the 
carrier gas. The flow rate was adjusted to 30 ml/minute. Injection sol-
vents were nanograde purity. The amount of sulfamethazine in each sample 
was determined by calculations based on peak height and a calculation 
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factor (C.F.) determined for the standard concentration by dividing the 
standard ng injected by the peak height obtained from the injection. The 
mean of three or more injections was used to determine the C.F. The peak 
height per ml of sample was averaged for two or more injections. This 
value multiplied by the C.F. gave the concentration per µl of sample 
(C/µl ). The C/µl x the dilution factor equaled the nanograms of drug in 
the sample (SNG). The SNG divided by the sample weight in grams x 1,000 
equaled ''uncorrected'' ppm. 
This value was corrected for recovery by multiplying the "uncorrect-
ed" value times 100 divided by percent recovery. Percent recovery was 
determined by the measured difference in a "spiked" sample vs. its "un-
spiked" duplicate. 
Statistical Evaluation 
Time study 
F-va 1 ues were determined from computed sums. of squares and mean 
squares for the calculated sulfamethazine concentrations for each time 
period. Statistical significance was assigned to F-values according to 
Snedecor and Cochran (1967) using a split-plot design as shown in Cox 
(1971). 
Freeze-thaw study 
F-values were determined from computed sums of squares and mean 
squares for the calculated sulfamethazine concentrations for each 
freeze-thaw cycle. Statistical significance was assigned to F-values 
according to Ostle and Mensing (1975) using a randomized block design. 
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RESULTS 
Time Study 
Control tissues-liver 
As measured by the Tishler color reaction, the uncorrected levels of 
"sulfamethazine" increased in both the blended and whole liver as the time 
the tissues were held at 23°C increased. The 48 hour and 96 hour values 
for blended liver were significantly higher (P < .05) than the values at 
shorter times. The 96 hour value for whole liver was significantly higher 
(P < .05) than values at shorter times. The uncorrected results for 
blended and whole liver as measured by the Tishler color reaction are 
shown in Table 1. A graphic illustration of these results is presented in 
Figure 2. 
Table 1. Uncorrected time study Tishler control liver values 
Blended liver-ppm Whole liver-ppm 
0 hours 0.06±0.02 0.03±0.01 
6 hours 0.10±0.05 0.04±0.01 
12 hours 0.10±0.04 0.04±0.01 
24 hours 0.11±0.04 0.06±0.02 
48 hours 0.23±0.12* 0 .10±0. 04 
96 hours 0. 30±0.11* 0 .38±0.15* 
* p < .05. 
0.50 
-E ~ 0.40 -
z 0.30 0 -!< 
0::: 0.20 t-
z 
U.I 
u z 0.10 0 
(..,) 
0 
0 
o--o WHOLE 
....... BLENDED 
6 12 24 
TIME (h) 
Figure 2. Uncorrected Tishler control liver values 
48 96 
N 
"' 
27 
The mean percent recovery values for the different time periods were 
variable but for both tissues were lowest at 96 hours. These values are 
shown in Table 2. 
Table 2. Mean percent recovery-time study control liver values 
Blended liver-ppm Whole liver-ppm 
0 hours 64±28 78±19 
6 hours 97±3 85±19 
12 hours 91±14 59±19 
24 hours 74±12 94±10 
48 hours 74±15 75±44 
96 hours 34±8 49±20 
The corrected values for whole and blended control liver parallel the 
uncorrected values. The 48 hour and 96 hour values for blended liver were 
significantly higher (P < .05) than the values at shorter times. The cor-
rected results for blended and whole liver as measured by the Tishler 
color reaction are shown in Table 3. A graphic illustration of these re-
sults is presented in Figure 3. 
Gas-liquid chromatographic analysis of liver samples from pigs fed 
sulfonamide-free feed revealed that with one exception, the samples for 
all time periods were negative. One sample, a O hour sample was found to 
contain 0.01 ppm sulfamethazine. Three other O hour samples were nega-
tive. This finding suggests this sample may have been contaminated-during 
the extraction procedures. Mean recovery for the negative samples was 
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Tabie 3. Corrected time study Tishler control liver values 
Blended liver-ppm Whole liver-ppm 
0 hours 0.07±0.01 0.04±0.01 
6 hours 0 .11±0 .04 0.05±0.01 
12 hours 0.10±0.03 0.06±0.01 
24 hours 0.16±0.01 0.07±0.04 
48 hours 0.35±0.04* 0.22±0.15 
96 hours 0. 50±0 .18* 0.68±0.12 
*P < • 05. 
87%. The 48 and 96 hour samples caused a problem with detector response 
and tended to greatly reduce sensitivity. 
Control tissues-muscle 
As measured by the Tishler color reaction, the uncorrected levels of 
"sulfamethazine" increased in the muscle from control animals as the time 
the tissues were held at 23°C increased. The 96 hour value was signifi-
cantly higher (P < .05) than the values for shorter times. The uncor-
rected results for control muscle values are shown in Table 4. A graphic 
illustration of the results is presented in Figure 4. 
The mean percent recovery values for the different time periods were 
variable but were lowest at 48 and 96 hours. These values are shown in 
Table 5. 
The corrected values for control muscle parallel the uncorrected 
values. The 96 hour value was significantly higher (P < .05) than the 
values for shorter times. The corrected control muscle values are shown 
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Table 4 .. Uncorrected time study Tishler control muscle values 
Muscle-ppm 
0 hours 0.02±0.01 
6 hours 0.03±0.01 
12 hours 0.03±0.01 
24 hours 0.03±0.01 
48 hours 0.03±0.01 
96 hours 0.07±0.01* 
* p < .05. 
Table 5. Mean percent recovery on time study control muscle samples 
Muscle 
0 hours 66±4 
6 hours 55±26 
12 hours 56±20 
24 hours 53±38 
48 hours 46±3 
96 hours 39±9 
in Table 6. A graphic illustration of these values is presented in 
Figure 5. 
Positive tissues-liver 
No significant differences were found in relation to treatment with 
time. As measured by the Tishler color reaction, the "sulfamethazine". 
level decreased in both the blended and whole liver through the first 48 
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Figure 4. Uncorrected Tishler control muscle values 
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Table 6. Corrected time study Tishler control muscle values 
0 hours 
6 hours 
12 hours 
24 hours 
48 hours 
96 hours 
* p < • 05. 
Muscle-ppm 
0.03±0.01 
0.06±0.03 
0.06±0.03 
0.06±0.03 
0.07±0.02 
0 .18±0. 03* 
hours and then increased between 48 and 96 hours. The change was not 
significant. 
The uncorrected results for blended and whole liver values are shown 
in Table 7. A graphic illustration of these results is presented in 
Figure 6. 
Table 7. Uncorrected time study Tishler positive liver values 
Blended liver-ppm Whole liver-ppm 
0 hours 0.26±0.07 0.28±0.07 
6 hours 0.24±0.09 0.26±0.07 
12 hours 0.20±0.06 0.23±0.06 
24 hours 0.16±0.04 0 .19±0. 02 
48 hours 0.10±0.10 0.16±0.04 
96 hours 0.30±0.06 0.33±0.04 
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The mean percent recovery values for the different time periods were 
variable. These values are shown in Table 8. 
Table 8. Mean percent recovery time study Tishler positive liver values 
Blended liver-ppm Whole liver-ppm 
0 hours 80±8 75 14 
6 hours 64±5 72±16 
12 hours 69±15 66±16 
24 hours 59±3 77±18 
48 hours 72±4 68±14 
96 hours 62±11 65±4 
The corrected results for blended and whole liver values are shown in 
Table 9. A graphic illustration of these results is shown in Figure 7. 
Table 9. Corrected time study Tishler positive liver values 
Blended liver-ppm Whole liver-ppm 
0 hours 0.36±0.12 0.41±0.15 
6 hours 0.35±0.16 0.41±0.17 
12 hours 0.32±-0.12 0 .39±0 .16 
24 hours 0.24±0.06 0.28±0.05 
48 hours 0 .15±0. 02 0.24±0.05 
96 hours 0 .49±0.10 0.50±0.07 
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Gas-liquid chromatography analysis of liver samples from pigs fed 
feed containing 11.0 ppm sulfamethazine revealed no difference between 
blended and unblended samples. The combined results are shown in Table 
10. The values in the table are corrected for recovery and mean recovery 
values are also included in this table. 
The values for the 0, 6, 12, and 24 hour samples are not significant-
ly different based on the GLC results. The values for the 48 and 96 
hour samples were ignored because these samples fouled the detector 
preventing accurate analysis. 
Table 10. GLC results on positive livers 
Liver~ppm Recovery % 
0 hours 0.25 45 
6 hours 0.20 50 
12 hours 0.26 40 
24 hours 0.24 38 
Positive tissue-muscle 
No significant differences were detectable by the Tishler method as 
the time increased. The values decreased up to 48 hours and then rose at 
96 hours. 
The uncorrected results for positive muscle values are shown in Table 
11. 
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Table 11. Uncorrected time study Tishler positive muscle values 
Muscle-ppm 
0 hours 0.08±0.03 
6 hours 0.07±0.03 
12 hours 0.06±0.01 
24 hours 0.06±0.02 
48 hours 0.06±0.03 
96 hours 0.09±0.02 
The mean percent recovery values for the different time periods were 
variable but were lowest at 96 hours. These values are shown in Table 12. 
The corrected results are shown in Table 13. 
Table 12. Percent recovery positive muscle 
Muscle 
0 hours 81±2 
6 hours 84±4 
12 hours 83±6 
24 hours 71±2 
48 hours 82±4 
96 hours 60±5 
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Table 13. Corrected time study Tishler positive muscle values 
Muscle-ppm 
O hours 0.09±0.03 
6 hours 0.08±0.03 
12 hours 0.08±0.02 
24 hours 0.08±0.02 
48 hours 0.08±0.04 
96 hours 0.13±0.03 
Freeze-Thaw Study 
Freeze thaw study - Tishler 
As measured by the Tishler col or reaction, the uncorrected and cor-
rected levels of "sulfamethazine" increased as the tissues were subjected 
to the freeze-thaw treatment. The value after 4 freeze-thaw cycles (FTC) 
wa'S significantly higher (P < .05) than the initial value. These results 
are shown in Table 14. A graphic illustration of these results are shown 
in Figure 8. 
Table 14. Tishler liver values after freeze-thaw treatment 
FTC Uncorrected-ppm Corrected-ppm 
1 0.04 0.04 
2 0.04 0.05 
3 0.05 0.06 
4 0.07* 0.09* 
* p < .05. 
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Figure 8. Tishler liver values after freeze-thaw treatment 
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Freeze-Thaw Study - GLC 
All liver samples from these pigs which were fed control feed were 
negative for sulfamethazine when analyzed by GLC. The mean percent re-
covery for these samples was 56%. A great majority of these samples con-
tained a substance which caused a significant response by the detector. 
The column retention time for this compound was approximately 1 minute 
longer than that for sulfamethazine. This peak tracing would begin to · 
rise before the tracing for sulfamethazine began to drop. This compound 
was identified as nicotinamide by gas-liquid chromatography-mass spec-
trometry. 
Control tissues 
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DISCUSSION 
Time Study 
The results of this study demonstrate that the "sulfonamide" concen-
tration in liver and muscle, as measured by the Tishler method of analy-
sis, can be affected if the tissue is stored at 23°C for some time. The 
effect of higher environmental temperatures is somewhat speculative but it 
is my opinion that the change would be accelerated at higher temperatures 
or relatively short storage time at higher temperatures coul.d change the 
value considerably. 
The difference in initial background concentrations of "sulfonamide" 
in the whole and blended liver samples from control animals may be due to 
rupture of cellular membranes by mechanical damage to the cells and/or the 
heat generated during the blending process. The difference in the levels 
suggests the effect of tissue treatment should be considered when doing 
collaborative studies between laboratories. The blended tissues would be 
more uniform samples but this treatment might influence the results of the 
study. The values in blended liver increased earlier than the whole liver 
values. This was probably caused by the same factors which created higher 
initial values in combination with an increase in available nutrients for 
putrifactive bacteria. Both values were at least 3 times their initial 
values at 48 hours and 5 times their initial values at 96 hours. Samples 
at these times were discolored and odoriferous. 
43 
The control muscle values also increased but not as quickly or to the 
extent of the liver values. Muscle would be a different type of media for 
bacterial growth and would probably contain fewer compounds readily con-
verted to primary aromatic amines. The change in the muscle value was not 
significant through 48 hours but was at 96 hours. 
Positive tissues 
The "sulfonamide" level, as.measured by the Tishler method of analy-
sis, for both blended and whole liver dropped over the first 48 hours and 
then rose again at 96 hours. The decrease in measured "sulfonamide" 
levels in samples from pigs fed 11.0 ppm sulfamethazine feed may be due to 
a process produced by the putrefactive bacteria which are multiplying in 
the tissue. These bacteria may be partially inhibited by the residual 
sulfamethazine and its active metabolites in the tissues. As the sulfa-
methazine is incorporated into the bacterial wall in place of PABA, the 
sulfamethazine may become unavailable for extraction. At the same time, 
this action would prevent bacterial degradation of the tissue components 
into primary aromatic amines. Metabolism of sulfamethazine by tissue en-
zymes may also contribute to the change in values. 
The measured amount of sulfamethazine in the muscle remained essential-
ly the same through the first 48 hours and increased slightly by 96 hours. 
The initial concentration of sulfamethazine was lower in the muscle than 
the liver. The muscle degradation may have been slowed by this small 
amount of sulfamethazine which eventually was depleted. 
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Freeze-Thaw Study 
The results demonstrate that the "sulfonamide level" of liver, as 
measured by the Tishler method of analysis, can be affected by repeated 
freezing and thawing. This finding suggests that samples should not be 
thawed for analysis and then refrozen for additional sulfonamide analyses. 
If a second analysis by this method is planned, the large sample should be 
divided while still frozen and only the portion of the sample to be ana-
lyzed allowed outside the freezer for a period of time sufficient to pro-
duce thawing. The portion to be analyzed should be processed promptly. 
If tissue is not frozen immediately after collection and kept frozen 
until analysis begins, the Tishler results may be erroneously high or low. 
Samples should be handled in such a way to insure that. they are taken from 
the animals as soon as possible and frozen within 30 minutes. Any sample 
arriving at the laboratory for analysis which is not frozen solid should 
be discarded. Samples which have partially thawed but still have some ice 
crystals in them may be undergoing some decomposition. Samples in the 
laboratory should be thawed quickly and the extraction procedures should 
begin as soon as possible. Samples should not be allowed to thaw out on a 
laboratory bench for an unspecified amount of time and samples which have 
thawed should not be frozen for later analysis. 
The nicotinamide detected by GLC in these samples could be confused 
with and interpreted as a sulfonamide peak. This finding suggests that 
careful monitoring of retention times using various sulfonamide standards 
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is necessary when analyzing field specime_ns which could contain a variety 
of sulfonamide compounds. 
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SUMMARY 
The literature on sulfonamide analysis and metabolism was reviewed. 
The Tisher method of analysis had been accepted as the "official" method 
of analysis by most laboratories. An extensive literature search failed 
to confirm this test as an "official" method. 
Selected tissues from control swine consuming sulfonamide-free feed 
were subjected to the effects of storage at a temperature of 23°C for 
various times and of freeze-thaw treatments. Similar tissues from swine 
consuming feed containing 11.0 ppm sulfamethazine were subjected to the 
effect of storage temperature. 
As measured by the Tishler color reaction, the "sulfonamide" concen-
tration in the tissues from the control animals increased as the time the 
tissues were held at 23° C increased. An increase in "sulfonamide" con-
centration was also detected by the Tishler method in control tissues sub-
jected to several freeze-thaw cycles. 
Analysis of the same control tissues by a GLC method failed to detect 
a change in concentration in these tissues. 
No si gni fi cant differences in "sulfonamide" concentrations were 
detected by the Tishler or GLC methods in tissues from animals consuming 
feed containing 11.0 ppm sulfamethazine. 
This study demonstrated that some types of tissue mishandling could 
alter the results obtained by the Tishler method of analysis. 
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